{
  "actions": [
    {
      "acted_at": "2005-05-11",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2005-05-11",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2005-05-23",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr2299-109",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "109",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2005-05-11",
  "number": "2299",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to establish therapeutic equivalence requirements for generic drugs, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Generic Drugs Access Act of 2005",
  "sponsor": {
    "bioguide_id": "P000034",
    "district": "6",
    "name": "Pallone, Frank, Jr.",
    "state": "NJ",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2005-05-11",
  "subjects": [
    "Administrative procedure",
    "Communication in medicine",
    "Department of Health and Human Services",
    "Drug approvals",
    "Federal preemption",
    "Generic drugs",
    "Government Operations and Politics",
    "Government paperwork",
    "Government publicity",
    "Health",
    "Law",
    "Local laws",
    "State laws"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2005-05-11",
    "date": "2005-06-21T19:44:52Z",
    "text": "Generic Drugs Access Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to include in an approval of an abbreviated application for a new drug a finding about whether the approved drug is the therapeutic equivalent of the previously approved or listed drug involved. Sets forth criteria for a drug to be established as therapeutically equivalent.\n\nProhibits a state or its political subdivision from establishing or continuing any requirement that does not conform to the therapeutic equivalence requirement of this Act."
  },
  "titles": [
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Generic Drugs Access Act of 2005",
      "type": "short"
    },
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Generic Drugs Access Act of 2005",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to establish therapeutic equivalence requirements for generic drugs, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2019-11-15T21:18:34Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/109/hr/BILLSTATUS-109hr2299.xml"
}